Embargo Policy

The embargo on all abstracts part of the 2018 ASCO-SITC Clinical Immuno-Oncology Symposium lifted at 5:00 p.m. ET on Monday, January 22, 2018.

Press Releases

  • Symposium Provides New Insights on Immunotherapy for Cancer
    SAN FRANCISCO – Eight noteworthy studies exploring the implications of immuno-oncology for patient care will be presented at the 2018 ASCO-SITC Clinical Immuno-Oncology Symposium. The meeting will take place January 25-27 at the San Francisco Marriott Marquis in San Francisco, California. These notable abstracts discuss the efficacy of immunotherapy in rare cancers, biomarkers to predict which patients will benefit most, and managing the adverse effects of immune-based treatments. Read the full release.

Meet the News Planning Team

  • Michael S. Sabel, MD, FACS
    University of Michigan
    American Society of Clinical Oncology
  • Mario Sznol, MD
    Yale School of Medicine and Yale Cancer Center
    American Society of Clinical Oncology
    Society for Immunotherapy of Cancer

Meeting Information

Meeting Publications

Past Meetings

2017 ASCO-SITC Clinical Immuno-Oncology Symposium

  • Response to Cancer Immunotherapy May Depend on Gut Bacteria
    ALEXANDRIA, Va. – Researchers have found a link between microbes in the gut (the microbiome) and response to immunotherapy. Read the full release.

  • Utility of Biomarkers for Predicting Colorectal Cancer Survival Depends on Tumor Location
    ALEXANDRIA, Va. – A large population-based study suggests that the utility of certain types of biomarkers, known as tumor-infiltrating lymphocytes (TILs), to predict colorectal cancer survival depends on where the tumor originates in the body. Read the full release.

Media Resources

How Can We Help You?